Understanding The Role of Rho GTPase in Cellular Processes (P12058)

Target Name: Rho GTPase

NCBI ID: P12058

Rho GTPase

Other Name(s): None

Understanding The Role of Rho GTPase in Cellular Processes

Rho GTPase (nonspecified subtype), also known as RhoA GTPase, is a protein that plays a crucial role in various cellular processes. It is a member of the Rho GTPase family, which is a group of GTPases that regulate various cellular processes, including cell signaling, cytoskeletal organization, and vesicle transport. Rho GTPase is a non-specified subtype of the Rho GTPase family, which means that it does not have a specific function or structure.

Rho GTPase is a protein that is expressed in many different cell types, including epithelial, muscle, and nervous cells. It is highly conserved, with similar sequences throughout its amino acid sequence. Rho GTPase is a cytoplasmic protein, which means that it is located in the cytoplasm of the cell. It is also a GTPase, which means that it canGDP to GDP.

Rho GTPase is involved in various cellular processes, including cell signaling, cytoskeletal organization, and vesicle transport. It is a key regulator of the RhoA signaling pathway, which is involved in cell signaling, cell division, and cell survival. Rho GTPase is also involved in the regulation of actinin, which is a protein that is involved in cytoskeletal organization.

Rho GTPase is a potential drug target and biomarker in various diseases. For example, it is a known target for the drug rapamycin, which is used to treat a variety of diseases, including cancer, aging, and neurodegenerative diseases. Rapamycin works by inhibiting the activity of Rho GTPase, which means that it can be used to treat diseases that are caused by the over activity of Rho GTPase.

Another potential drug target for Rho GTPase is the protein Kinesin-2, which is involved in cell division and cytoskeletal organization. The inhibition of Rho GTPase has been shown to increase the activity of Kinesin-2, which can lead to the breakdown of tight junctions, which are responsible for the separation of cells in the body. This can lead to the development of various diseases, including cancer.

In addition to its potential as a drug target, Rho GTPase is also a potential biomarker for several diseases. For example, it is has been shown to be involved in the development and progression of cancer. The inhibition of Rho GTPase has been shown to reduce the growth and spread of cancer cells. Additionally, Rho GTPase is involved in the regulation of actinin, which is a protein that is involved in cytoskeletal organization. The disruption of actinin has been shown to contribute to the development of various diseases, including cancer.

In conclusion, Rho GTPase is a non-specified subtype of the Rho GTPase family that plays a crucial role in various cellular processes. It is highly conserved and involved in the regulation of cell signaling, cytoskeletal organization, and vesicle transport. Rho GTPase is also involved in the regulation of actinin and has been shown to be a potential drug target and biomarker in various diseases. Further research is needed to fully understand the role of Rho GTPase in cellular processes and its potential as a drug target and biomarker.

Protein Name: Rho GTPase (nonspecified Subtype)

The "Rho GTPase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Rho GTPase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets